Page 1 of Clinical Trials for Shandong Cancer Hospital and Institute [SPONSOR-COLLABORATORS], 7 Total Matches
- 1CompletedLast Updated: February 4, 2011Condition(s): Esophageal Cancer
- 2Not yet recruitingLast Updated: April 24, 2012Condition(s): PHENYTOIN/SORAFENIB [VA Drug Interaction]; Liver Neoplasms; Carcinoma, Hepatocellular; Digestive System Neoplasms; Neoplasms by Site; Liver Diseases; Adenocarcinoma; Carcinoma; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type; DOXORUBICIN/TRASTUZUMAB [VA Drug Interaction]; HBV
- 3Enrolling by invitationLast Updated: January 27, 2012Condition(s): Epigallocatechin Gallate; Radio Dermatitis; Radiation Mucositis
- 4Not yet recruitingLast Updated: May 21, 2012Condition(s): PHENYTOIN/SORAFENIB [VA Drug Interaction]; Carcinoma, Hepatocellular
- 5RecruitingLast Updated: November 28, 2011Condition(s): Small Cell Lung Carcinoma
- 6RecruitingLast Updated: November 30, 2011Condition(s): Rectal Cancer; Treatment; Postoperative Complications; Neoplasm Recurrence, Local; Survival Rate
- 7RecruitingLast Updated: July 27, 2010Condition(s): Gallbladder Neoplasms
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Shandong+Cancer+Hospital+and+Institute
